A new drug discovery technique, which uses mixed-mode sorbents in
process chromatography, has the potential to significantly reduce
costs and environmental burdens, especially in the protein
In its second acquisition in less than a month, Millipore has
acquired bioprocessing products firm Serologicals for around $1.4bn
(€1bn) in cash, as it tries to boost its growth by expanding in
potentially lucrative market segments.
As the threat of new viruses like avian influenza have heightened
the need for greater speed and safety in vaccine production, single
use technologies are proving far more safe and economic than
traditional cleaning techniques, according...
Thanks to a £2.7m (€3.9m) access fund from the UK's National
Biomanufacturing Centre (NBC), biotech firm Onyvax has hired
contract manufacturer organisation (CMO) Eden Biodesign to supply
it with clinical current good manufacturing...
Kreatech has launched the first complete miRNA isolation and
labelling kit, which combines the upstream isolation of small RNA
and the reagents necessary to label these DNA samples for
microarray analysis, offering a more complete...
A new laboratory method for distinguishing pathogens from harmless
relatives has been developed by scientists in the US. The
high-throughput technique will enable the quick identification of
pathogens, which could be used for bioterror...
GE Healthcare has announced the introduction of Ettan nanoLC, a
fully bio-inert, robust, nanoscale peptide separation system that
delivers highly reproducible performance and is ideal for 1D-liquid
chromatography (LC) proteomics applications...
The production capacity for biopharmaceutical manufacturing will
expand an average of 48 per cent over the next five years for
mammalian and microbial production systems, according to an
Hamilton launches two new products, which are set to aid the
facilitation of automation in laboratories, placing tedious and
time-consuming processes in the hands of cutting edge and
cost-effective technology for automation.
US scientists have shown that microRNA (miRNA) plays an essential
role in the development of the fruit fly. The discovery means that
miRNA could emerge as a new target for interventions aimed at
treating disease, or as a therapeutic...
The use of DNA as a vaccine has been an exciting but elusive
prospect in drug development for many years, held back by problems
with effectivness and difficulties in production. But this could be
about to change, reports Phil Taylor.
According to a new report the therapeutic antibody market is
expected to treble in size by 2010 as significant leaps forward
coupled with safer and more effective humanised and fully human
antibodies are pouring onto the market fulfilling...
Millipore has introduced a single-use prefilter for clarification
steps in mammalian cell synthesis that continues the trend towards
increasing use of disposable technologies in the bioprocessing
environment, reports Phil Taylor.